Shanghai Pharmaceutical (601607.SH) subsidiary plans to sell 41% of Shanghai Pharmaceutical (Shanghai) Co., Ltd.

Zhitongcaijing · 1d ago

Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) announced that Shanghai Pharmaceutical Holdings Co., Ltd., a subsidiary of the company, plans to transfer 41% of the shares of the holding subsidiary Shanghai Pharmaceutical (Shanghai) Co., Ltd. through public listing on the property rights exchange. The listing transfer price is proposed to be 330 million yuan (in the end, it should not be lower than the assessed value registered through state-owned assets assessment). The final transfer price is based on the results of the public listing transaction. After the transaction is completed, Shanghai Pharmaceutical will hold 10% of the shares in the target company through Shanghai Pharmaceutical Holdings and will no longer carry out mergers with the target company.

This transaction is an important strategic move by Shanghai Pharmaceutical to promote the overall development of the new retail business and further enhance its overall competitiveness. It aims to comprehensively enhance its market value and core competitiveness by integrating professional pharmacy resources within the Shanghai pharmaceutical system.